Echinococcus (Hydatid Cyst) IgG

Lung

Report in 96Hrs

At Home

No Fasting Required

Details

Antibody test for hydatid disease.

₹2,139₹3,055

30% OFF

Echinococcus (Hydatid Cyst) IgG Test Information Guide

Why is it done?
- Detects IgG antibodies against Echinococcus parasites to diagnose hydatid disease (echinococcosis), a parasitic infection caused by tapeworms
- Identifies cyst-forming parasitic infections in organs such as liver, lungs, brain, kidneys, and spleen
- Ordered when patients present with unexplained cystic masses on imaging studies (ultrasound, CT, or MRI)
- Used to confirm suspected hydatid disease in patients with compatible clinical symptoms
- Performed in patients with exposure history to Echinococcus (contact with infected dogs or consumption of contaminated food/water)
- Helps differentiate hydatid cysts from other cystic lesions and differential diagnoses
- May be performed as screening in endemic areas or high-risk populations
Normal Range
- Negative Result: IgG antibodies not detected or value < 0.9 index (varies by laboratory); indicates no current or past Echinococcus infection
- Borderline/Equivocal Result: Index value 0.9-1.1 (laboratory-dependent); may indicate early infection, past infection, or cross-reactivity; repeat testing recommended
- Positive Result: IgG antibodies detected or value > 1.1 index; indicates current or past Echinococcus infection
- Units of Measurement: Index value (unitless) or reported as positive/negative; may also be reported as antibody titer or enzyme immunoassay (EIA) optical density units
- Normal vs Abnormal: Normal (negative) results suggest absence of Echinococcus infection; abnormal (positive) results indicate presence of parasitic infection, though timing (acute vs chronic) cannot be determined by IgG alone
Interpretation
- Positive IgG Result: Indicates exposure to Echinococcus parasites and development of immune response; consistent with active or past hydatid disease; requires imaging confirmation (ultrasound/CT) and clinical correlation
- Negative IgG Result: Suggests no current or past Echinococcus infection; does not completely exclude very early infection (pre-antibody formation phase) or heavily calcified cysts with minimal immune response
- Higher Antibody Titers: May indicate active or progressive infection; tend to decrease with successful treatment or cyst calcification; rising titers suggest disease progression
- Factors Affecting Results: Cross-reactivity with other helminth infections; immunocompromised patients may have false-negative results; intact vs ruptured cysts affect antibody levels; time since infection influences antibody presence
- Clinical Significance: Positive result in patient with imaging findings consistent with hydatid cysts is highly suggestive of echinococcosis; must be combined with clinical presentation and imaging findings for definitive diagnosis; serial testing useful for monitoring treatment response
- Species Differentiation: IgG test cannot differentiate between Echinococcus species (E. granulosus, E. multilocularis, E. vogeli, E. oligarthrus); specialized testing needed for species identification when clinically important
Associated Organs
- Primary Organ Systems Involved: Hepatic (liver - most common, 60-70% of cases), pulmonary (lungs - second most common, 20-30%), renal (kidneys), splenic, cardiac, neurological (brain), and peritoneal cavity
- Echinococcosis (Hydatid Disease): Parasitic infection caused by Echinococcus tapeworms; humans infected via consumption of food/water contaminated with eggs or direct contact with infected animals (dogs, sheep, cattle)
- Hepatic Cystic Echinococcosis: May cause abdominal pain, hepatomegaly, cholestasis, jaundice, and bile duct obstruction
- Pulmonary Cystic Echinococcosis: May cause cough, hemoptysis, chest pain, dyspnea, and respiratory complications including cyst rupture
- Alveolar Echinococcosis: Caused by E. multilocularis; more aggressive; primarily affects liver with potential metastatic spread; associated with higher mortality if untreated
- Neurological Involvement: Cerebral hydatid cysts may cause seizures, headaches, focal neurological deficits, increased intracranial pressure, and stroke
- Complications of Abnormal Results: Cyst rupture causing anaphylactic reactions, secondary infections, spillage of parasitic material, organ dysfunction, surgical emergencies, chronic infection complications
- Risk Factors for Infection: Occupational exposure (farmers, sheepherders), endemic area residence (Mediterranean, Middle East, South America, Central Asia), poor sanitation, dog ownership without deworming
Follow-up Tests
- Imaging Studies: Abdominal ultrasound or CT scan (for hepatic cysts); chest X-ray or CT (for pulmonary cysts); MRI brain (for cerebral cysts); organ-specific imaging based on clinical suspicion
- Echinococcus IgM Testing: May be ordered to assess for acute or recent infection (IgM indicates acute phase response)
- Western Blot or Immunoblot: Confirmatory test for equivocal or borderline IgG results; provides species identification in some laboratories
- Molecular PCR Testing: May be performed on tissue samples or cyst fluid for definitive species identification and diagnosis
- Liver Function Tests (LFTs): Bilirubin, alkaline phosphatase, transaminases to assess hepatic cyst impact
- Complete Blood Count (CBC): May show eosinophilia in acute infections
- Serial Antibody Titers: Repeated IgG testing at 3-6 month intervals to monitor treatment response; decreasing titers indicate successful therapy; rising titers suggest disease progression
- Aspiration Cytology or Biopsy: May be performed on cyst fluid for parasite identification (protoscolices, hooklets)
- Parasitology Studies: Stool examination for Echinococcus eggs (primarily to detect in animal vectors); rarely positive in human infections
- Monitoring Frequency: Baseline serology upon diagnosis; repeat serology every 3-6 months during treatment; continue monitoring post-treatment for 2-5 years to detect relapse or recurrence
Fasting Required?
- Fasting Status: No - fasting is NOT required for this test
- Blood Draw Instructions: Standard venipuncture; blood collected in serum separator tube (SST) or red-top tube; no special collection requirements
- Medications: No medications need to be avoided; continue all regular medications as prescribed
- Preparation: Arrive with or without food/drink; stay hydrated; sit or lie down during blood draw; no special preparation needed
- Timing: Can be performed at any time of day; no time-dependent restrictions
- Specimen Handling: Allow blood to clot if using SST; refrigerate if transportation delayed; stable at room temperature for 24 hours; reference laboratory testing may require frozen serum storage
- Sample Volume: Typically 5-10 mL of serum required; confirm volume with testing laboratory

How our test process works!